Mark D. Booth
Keine laufenden Positionen mehr
Profil
Mark D.
Booth formerly worked at Abbott Laboratories, as Division VP & GM-Anti-Infective & GI Franchise, Immunex Corp., as SVP-Operations & General Manager from 2000 to 2001, Assertio Therapeutics, Inc., as Chief Commercial Officer & Senior Vice President, Orexigen Therapeutics, Inc., as Chief Commercial Officer from 2009 to 2015, Takeda Pharmaceuticals U.S.A., Inc., as President in 2008, and Vivoryon Therapeutics NV, as Chief Business Officer in 2016.
Mr. Booth received his undergraduate degree in 1981 from Northern Illinois University and Masters Business Admin degree in 1997 from Kellogg School of Management.
Ehemalige bekannte Positionen von Mark D. Booth
| Unternehmen | Position | Ende |
|---|---|---|
| VIVORYON THERAPEUTICS N.V. | Corporate Officer/Principal | 15.08.2016 |
| OREXIGEN THERAPEUTICS, INC. | Corporate Officer/Principal | 30.09.2015 |
Takeda Pharmaceuticals U.S.A., Inc.
 Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals U.S.A., Inc. develops and markets pharmaceutical products. It offers metabolic and cardiovascular, respiratory and immunology, central nervous system, oncology, and general medicine products. The company was founded in 1998 and is headquartered in Deerfield, IL. | Präsident | 01.06.2008 |
Immunex Corp.
 Immunex Corp. BiotechnologyHealth Technology Immunex Corporation is a leading biopharmaceutical company dedicated to improving lives through immune system science innovation | Geschäftsführer | 01.09.2001 |
| ABBOTT LABORATORIES | Corporate Officer/Principal | - |
Ausbildung von Mark D. Booth
| Northern Illinois University | Undergraduate Degree |
| Kellogg School of Management | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| VIVORYON THERAPEUTICS N.V. | Health Technology |
| ABBOTT LABORATORIES | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Orexigen Therapeutics, Inc.
 Orexigen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Orexigen Therapeutics, Inc. is a biopharmaceutical company, which focuses on the development of pharmaceutical product candidates for the treatment of obesity. Its primary activities include recruiting personnel, conducting research and development, including clinical trials, raising capital, and preparing for the marketing and commercialization of its product, contrave. The company was founded by Eckard Weber in September 2002 and is headquartered in La Jolla, CA. | Health Technology |
Takeda Pharmaceuticals U.S.A., Inc.
Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals U.S.A., Inc. develops and markets pharmaceutical products. It offers metabolic and cardiovascular, respiratory and immunology, central nervous system, oncology, and general medicine products. The company was founded in 1998 and is headquartered in Deerfield, IL. | Health Technology |
Immunex Corp.
Immunex Corp. BiotechnologyHealth Technology Immunex Corporation is a leading biopharmaceutical company dedicated to improving lives through immune system science innovation | Health Technology |
Assertio Therapeutics, Inc.
 Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | Health Technology |
